BioCentury
ARTICLE | Clinical News

Strathspey's Alphaeon subsidiary submits BLA to FDA for frown lines candidate

June 9, 2017 7:50 PM UTC

The Alphaeon Corp. subsidiary of Strathspey Crown Holdings LLC (Newport Beach, Calif.) said that its Evolus Inc. unit submitted a BLA to FDA for DWP-450 to treat adults with glabellar lines, also kno...

BCIQ Company Profiles

Strathspey Crown Holdings LLC